Clinical Trial

Efficacy and Safety of Electroacupuncture for ICU Sepsis Patients

Study acronym: SEPSIS-ACU
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of electroacupuncture (EA) combined with standard Intensive Care Unit (ICU) therapy on organ dysfunction and other clinical outcomes in sepsis patients. Additionally, this study will conduct subgroup analyses to investigate the influence of septic shock and immunomodulators on the treatment effects and their correlation with electroacupuncture efficacy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-28.
Status change: Not Yet Recruiting → Recruiting 2025-04-15
Trial Details
NCT Number NCT06666946
Lead Sponsor Shusheng Li
Conditions Sepsis
Enrollment 308 participants
Start Date 2025-02-11
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-18